Apotex Inc. v. UCB, Inc., No. 13-1674 (Fed. Cir. Aug. 15, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Apotex Inc. and Apotex Corp. (collectively, “Apotex”) appeal the decision of the United States District Court for the Southern District of Florida finding that : (1) Apotex’s U.S. Patent No. 6,767,556 (“the ’556 p atent”) is une n- forceable due to inequitable conduct; (2) Apotex is jud i- cially estopped from alleging infringement of the ’556 patent by the accused products; (3) the asserted claims are indefinite ; (4) A potex disclaimed coverage of the accused produ cts from the scope of the ’556 patent’s claims;…